^
    Back
    Association details:
    Biomarker:EGFR H773delinsYNPY
    Cancer:Lung Cancer
    Drug:Tagrisso (osimertinib) (EGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    JTO Clin Res Rep
    Title:

    Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

    Published date:
    07/26/2023
    Excerpt:
    LTO9 cells harboring EGFR H773delinsYNPY were sensitive to osimertinib.
    DOI:
    https://doi.org/10.1016/j.jtocrr.2023.100554